The Rubicon Research Ltd IPO date has been confirmed from October 09, 2025, and closes on October 13, 2025. Read the post to learn about Rubicon Research Ltd IPO GMP.
Rubicon Research Ltd. IPO is a book build issue of ₹1,377.50 crores. The issue is a combination of fresh issue of 1.03 crore shares aggregating to ₹500.00 crores and offer for sale of 1.81 crore shares aggregating to ₹877.50 crores. Rubicon Research IPO price band is set at ₹461.00 to ₹485.00 per share . The lot size for an application is 30. The minimum amount of investment required by an retail is ₹14,550 (30 shares) (based on upper price). The lot size investment for sNII is 14 lots (420 shares), amounting to ₹2,03,700, and for bNII, it is 69 lots (2,070 shares), amounting to ₹10,03,950.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Oct 09- Oct 13Price Range
₹461 to ₹485 per shareFace Value
₹1 per shareGMP
₹68Rubicon Research Ltd IPO GMP
The Rubicon Research Ltd IPO GMP Today is ₹68.
IPO Overview
Rubicon Research IPO opens for subscription on Oct 9, 2025 and closes on Oct 13, 2025. The allotment for the Rubicon Research IPO is expected to be finalized on Oct 14, 2025. Rubicon Research IPO will list on BSE, NSE with a tentative listing date fixed as Oct 16, 2025.
Rubicon Research Ltd IPO Details
| IPO Date | October 9, 2025 to October 13, 2025 |
| Listing Date | [.] |
| Face Value | ₹1 per share |
| Issue Price Band | ₹461 to ₹485 per share |
| Lot Size | 30 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 2,84,02,040 shares (aggregating up to ₹1,377.50 Cr) |
| Fresh Issue | 1,03,09,278 shares (aggregating up to ₹500.00 Cr) |
| Offer for Sale | 1,80,92,762 shares of ₹1 (aggregating up to ₹877.50 Cr) |
| Employee Discount | ₹48.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 15,44,37,251 shares |
| Share Holding Post Issue | 16,47,46,529 shares |
Rubicon Research Ltd Financial Information
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 1,647.60 | 1,451.43 | 1,109.49 | 749.70 |
| Total Income | 356.95 | 1,296.22 | 872.39 | 419.00 |
| Profit After Tax | 43.30 | 134.36 | 91.01 | -16.89 |
| EBITDA | 79.74 | 267.89 | 173.09 | 43.97 |
| NET Worth | 593.67 | 540.98 | 385.00 | 286.38 |
| Reserves and Surplus | 397.50 | 525.57 | 369.79 | 281.31 |
| Total Borrowing | 495.78 | 393.17 | 396.41 | 317.91 |
| Amount in ₹ Crore | ||||
Rubicon Research Ltd IPO Timeline
| IPO Open Date | Thu, Oct 9, 2025 |
| IPO Close Date | Mon, Oct 13, 2025 |
| Tentative Allotment | Tue, Oct 14, 2025 |
| Initiation of Refunds | Wed, Oct 15, 2025 |
| Credit of Shares to Demat | Wed, Oct 15, 2025 |
| Tentative Listing Date | Thu, Oct 16, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mon, Oct 13, 2025 |
Company Profile
Rubicon Research is a global pharmaceutical formulations company committed to developing innovative, value-added products that improve lives worldwide. Established in 1999, the company has evolved from providing contract formulation services to becoming a fully integrated developer, manufacturer, and marketer of branded specialty and generic prescription products. With state-of-the-art R&D centers in India and Canada, and US FDA-inspected manufacturing facilities in Maharashtra, Rubicon delivers high-quality oral, nasal, and ophthalmic formulations to regulated markets. Through its subsidiaries AdvaGen Pharma and Validus, the company continues to strengthen its presence in the US while expanding globally across key regions including Australia, the UK, and the Middle East.
Registrar Info
| Name | MUFG Intime India Pvt.Ltd. |
| Phone number | +91-22-4918 6270 |
| Email ID | rubicon.ipo@linkintime.co.in |
| Website | https://linkintime.co.in/Initial_Offer/public-issues.html |
Contact Details
| Name | Rubicon Research Ltd |
| Phone number | 022 61414000 |
| Email ID | investors@rubicon.co.in |
| Website | https://www.rubicon.co.in/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Rubicon Research Ltd IPO FAQs
When Rubicon Research IPO will open?
The Rubicon Research IPO opens on October 9, 2025 and closes on October 13, 2025.
What is the lot size of Rubicon Research IPO?
Rubicon Research IPO lot size is 30, and the minimum amount required for application is ₹14,550.
When is Rubicon Research IPO listing date ?
The Rubicon Research IPO listing date is not yet announced. The tentative date of Rubicon Research IPO listing is Thursday, October 16, 2025.